We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protective Coating Helps Leishmania to Resist Macrophage Digestion

By Biotechdaily staff writers
Posted on 12 Aug 2003
Researchers studying the molecular mechanism that allows the leishmania parasite to survive inside macrophages, blood cells that usually destroy pathogenic microorganisms, have found that while the major surface lipophosphoglycan (LPG) is critical to the survival of the parasite, other molecules must collaborate with it.

Epidemiologists estimate that about 12 million people worldwide are infected with leishmania parasites. More...
The parasite is spread by the bite of sand flies and causes various types of cutaneous and visceral diseases.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) focused their studies on the role of LPG, which is abundantly expressed on the surface of parasite. Their paper published July 17, 2003, in the online edition of Proceedings of the National Academy of Sciences described the use of a strain of the parasite that was genetically engineered to lack the gene for LPG production.

Parasites without LPG were found to be ten times more vulnerable to attack by complement, and although parasites that lacked LPG invaded macrophages, they were quickly destroyed by oxidative mechanisms once inside the cells. On the other hand, parasites without LPG retained the ability to resist macrophage hydrolytic and proteolytic defenses.

"This study helps us better understand how these parasites are transmitted and how they establish infections,” said senior author Dr. Stephen M. Beverley, professor of molecular microbiology at Washington University. "It also could help efforts leading to the development of a vaccine to prevent this devastating disease.”




Related Links:
Washington University

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.